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Hemoglobin is an important oxygen-carrying protein and plays crucial 23 
roles in establishing host resistance against pathogens and regulating innate 24 
immune responses. The hemoglobin subunit beta (HB) is an essential 25 
component of hemoglobin, and we have previously demonstrated that the 26 
antiviral role of the porcine HB (pHB) is mediated by promoting the type I 27 
interferon pathways. Thus, considering the high homology between human 28 
HB (hHB) and pHB, we hypothesized that hHB also play an important role in 29 
the antiviral innate immunity. In this study, we characterized hHB as a 30 
regulatory factor for the replication of RNA viruses by differentially regulating 31 
the RIG-I- and MDA5-mediated antiviral signaling pathways. Furthermore, we 32 
showed that hHB directly inhibited the MDA5-mediated signaling through 33 
reducing the MDA5-dsRNA affinity. Additionally, hHB required hHB-induced 34 
reactive oxygen species to promote the RIG-I-mediated signaling through 35 
enhancing the K63-linked RIG-I ubiquitination. Taken together, our findings 36 
suggest that hHB is a pleiotropic regulator of the RIG-I/MDA5-mediated 37 
antiviral responses and further highlight the importance of intercellular 38 
microenvironment including redox state in regulating the antiviral innate 39 
immune responses. 40 
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Hemoglobin, the most important oxygen-carrying protein, is involved in 47 
the regulation of innate immune responses. We have previously reported that 48 
the porcine hemoglobin subunit beta (HB) exerts an antiviral ability through 49 
regulating the type I interferon production. However, the antiviral activities 50 
and the underlying mechanisms of HBs originated from other animals have 51 
been poorly understood. Here, we identified human HB (hHB) as a pleiotropic 52 
regulator of the replication of RNA viruses through regulating the 53 
RIG-I/MDA5-mediated signaling pathways. hHB enhances the RIG-I 54 
mediated antiviral responses through promoting the RIG-I ubiquitination 55 
depending on the hHB-induced reactive oxygen species (ROS), while it 56 
blocks the MDA5-mediated antiviral signaling through suppressing the 57 
MDA5-dsRNA interaction. Our results contribute to understand the crucial 58 
roles of hHB in the regulation of the RIG-I/MDA5-mediated signaling 59 
pathways. We also provide a novel facet to the correlation of the intercellular 60 
redox state with the regulation of antiviral innate immunity.  61 
  62 
 63 




Type I interferons (IFNs) establish the first line of defense against viruses 66 
(1). They are activated in response to signaling cascades initiated by the 67 
effective interactions between the genetically encoded host pattern 68 
recognition receptors (PRRs) and pathogen-associated molecular patterns 69 
(PAMPs) (2). Viral nucleic acid is one of the well-characterized PAMPs. 70 
Depending on the genetic nature of viruses, the retinoic acid-inducible gene I 71 
(RIG-I)-like receptors (RLRs) function as the key viral RNA sensors and 72 
mediators of IFN-production (3, 4). 73 
RIG-I and melanoma differentiation-associated gene 5 (MDA5) are major 74 
members of RLRs and contain a central DExD/H box helicase domain, which 75 
is responsible for recognizing viral RNA, and two caspase recruitment 76 
domains (CARD) at their N-terminal regions (5). Upon sensing viral RNA, 77 
RIG-I and MDA5 undergo conformational alterations and interact with the 78 
adaptor mitochondrial antiviral signaling protein (MAVS, also called IPS-1, 79 
VISA, or Cardif) through the CARD domains (6, 7). Acting as a central adaptor, 80 
MAVS initiates downstream antiviral signaling through activating the 81 
downstream IKK-α/β/γ and TBK1/IKKi kinases, resulting in the activation of 82 
NF-B and IRF3/IRF7 to transcriptionally induce the type I IFNs (8-10). 83 
RIG-I and MDA5 share high structural homologies and signaling features 84 
(11). However, they sense different species and natures of viral RNAs (12). It 85 
is now well established that RIG-I primarily senses the 5-triphosphate 86 
(5ppp)-containing viral RNAs and some specific sequence motifs in the viral 87 
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RNA, such as poly(U/UC) (13-15). In contrast to RIG-I, the characteristics of 88 
viral PAMPs sensed by MDA5 activation remain elusive. It has been 89 
proposed that MDA5 can recognize long dsRNA as well as web-like RNA 90 
aggregates (16). As countermeasures, it has been shown that RIG-I- and 91 
MDA5-mediated signaling pathways are differentially regulated (5). Some 92 
viral proteins exert different effects on the RIG-I- and MDA5-mediated 93 
pathways. For instance, the paramyxovirus V protein regulates the MDA5- but 94 
not RIG-I-mediated signaling (17). Besides viral proteins, numerous host 95 
molecules have been identified to regulate the RIG-I-mediated signaling. The 96 
ARF-like protein 16 (Arl16) and the anti-apoptotic protein A20 interact with 97 
RIG-I to inhibit antiviral responses (18, 19); cylindromatosis (CYLD) and 98 
ubiquitin specific peptidase 21 (USP21) remove K63-linked polyubiquitin 99 
chains to suppress the RIG-I-mediated signaling (20, 21), and ring-finger 100 
protein 125 (RNF125) can trigger the proteasome-mediated degradation of 101 
RIG-I (22). Several MDA5-associated host proteins have also been identified, 102 
such as ADP-ribosylation factor-like protein 5B (Arl5B) and dihydroacetone 103 
kinase (DAK) (23, 24). However, the regulatory mechanisms of these two 104 
RLRs are insufficiently understood. 105 
Hemoglobin is the main oxygen-carrying protein in vertebrates and many 106 
invertebrates, and in adult humans, it exists as a tetramer composed of two 107 
α-chains and two β-chains (25). The old belief of hemoglobin expression 108 
indicates that hemoglobin is expressed only by the erythroid cells. However, 109 
this belief has been challenged by the recent findings that hemoglobin is 110 
expressed in a wide variety of non-erythrocytes including hepatocytes, 111 
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alveolar cells, neuronal/glial cells, and endometrial cells (26-29). Hemoglobin 112 
exerts multiple functions and plays important roles in resistance to the 113 
invasion of pathogens and the regulation of the innate immunity (30, 31). 114 
Peptides derived from hemoglobin have a great potential as therapeutic drug 115 
candidates (32, 33). However, the antiviral activities and the underlying 116 
mechanisms of hemoglobin are poorly explored. Previously, for the first time, 117 
we have corroborated that the porcine hemoglobin subunit beta (pHB) is able 118 
to suppress the growth of classical swine fever virus (CSFV) through the 119 
regulation of the RIG-I-mediated type I IFN responses (34). However, the 120 
roles of the HBs of other species in innate immunity have not yet been 121 
determined. Due to the significant amino acid homology (84.4%) between 122 
human HB (hHB) and pHB, we speculated that they have functional 123 
homologies in regulating antiviral innate immunity. 124 
In the present study, we identified hHB as a pleiotropic regulator of the 125 
innate antiviral immunity through regulating the RIG-I/MDA5-mediated 126 
signaling pathways. We investigated the molecular mechanisms underlying 127 
the hHB-induced differential regulation of the RIG-I- and MDA5-mediated 128 
type I IFN responses in humans. Our results illustrate the importance of hHB 129 
in regulating antiviral responses and provide novel insights into functional 130 
differences in the RIG-I- and MDA5-mediated antiviral innate immunity.  131 
 132 
Results 133 
hHB is involved in the defense responses against RNA viruses.  134 
To verify whether hHB modulates host antiviral responses, we first 135 
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evaluated the content of hHB in different non-erythroid cell lines. The 136 
expression analysis showed that hHB was expressed in the cell lines derived 137 
from various tissue cells, including kidney cells (HEK293T), liver cells 138 
(HepG2), lung cells (A549), cervix cells (HeLa), and peripheral blood 139 
mononuclear cells (THP-1) (Fig. 1A). To investigate the effect of hHB on the 140 
infection of RNA viruses, we generated hHB-deficient HEK293T (hHB-/-) cells 141 
using the CRISPR/Cas9 system, resulting in efficient knockout of hHB, and 142 
overexpressed hHB in HEK293T cells (Fig. 1B). Higher viral replication was 143 
observed in hHB-/- cells when infected with Sendai virus (SeV), vesicular 144 
stomatitis virus (VSV), and Newcastle disease virus (NDV), but lower 145 
replication of encephalomyocarditis virus (EMCV) was exhibited in hHB-/- cells 146 
(Fig. 1C). Accordingly, overexpression of hHB led to the resistance to SeV, 147 
VSV, or NDV infection, but enhancement of the growth of EMCV (Fig. 1D). 148 
Taken together, these results indicate that hHB can regulate the replication of 149 
RNA viruses. 150 
 151 
hHB promotes the RIG-I-mediated antiviral signaling. 152 
RIG-I and MDA5 function as key viral RNA sensors through recognizing 153 
different viral RNA species (12). While many negative-stranded RNA viruses 154 
including SeV, VSV, and NDV are mainly sensed by RIG-I, the viral RNA of 155 
picornaviruses such as EMCV is almost exclusively recognized by MDA5 (12). 156 
In conjunction to aforesaid results, hHB exerted an antiviral function against 157 
SeV, VSV, and NDV. However, hHB appeared to be beneficial for the 158 
replication of EMCV. Therefore, we speculated that hHB may differentially 159 
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regulate the RIG-I- and MDA5-mediated signaling pathways to modulate 160 
antiviral immune responses. We first explored the contribution of hHB in the 161 
RIG-I-mediated signaling and noticed that overexpression of hHB significantly 162 
enhanced the RIG-I-induced activations of the IFN-β promoter and ISRE, 163 
which was saturated at high concentrations (0.7-0.8 μg) (Fig. 2A and B). 164 
Consistently, hHB also promoted the IFN-β promoter activation in the cells 165 
stimulated with cytoplasmic short poly(I:C), which is a specific ligand of RIG-I 166 
(Fig. 2C). In addition, overexpression of hHB upregulated the RIG-I- or short 167 
poly(I:C)-induced transcriptions of IFN-β, and IFN-stimulated genes including 168 
GBP1 and ISG56 (Fig. 2D–F).  169 
We also determined the impact of hHB knockout on the RIG-I-mediated 170 
signaling pathway. Dual-luciferase reporter assay indicated that RIG-I- and 171 
short poly(I:C)-induced activations of the IFN-β promoter and ISRE were 172 
significantly impaired in hHB-/- cells (Fig. 2G and H). Correspondingly, lower 173 
mRNA levels of IFN-β, GBP1, and ISG56 were observed in the RIG-I- or short 174 
poly(I:C)-treated hHB-/- cells (Fig. 2I–K). These results highlight the 175 
involvements of RIG-I in hHB-mediated regulation of type I IFNs. To exclude 176 
the possibility that hHB can activate the IFN-β transcription by itself, we 177 
investigated the effect of the hHB-overexpression on the activation of the 178 
IFN-β promoter. The luciferase measurements showed that hHB was unable 179 
to activate the IFN-β promoter in HEK293T cells by itself (Fig. 2L). 180 
 181 
hHB inhibits the MDA5-mediated antiviral signaling. 182 
We next investigated the contribution of hHB in MDA5-mediated type I 183 
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IFN signaling. We examined the activation of IFN-β promoter and ISRE in 184 
hHB and MDA5 cotransfected HEK293T cells. The results demonstrated that 185 
overexpression of hHB significantly decreased the MDA5-induced IFN-β 186 
promoter and ISRE activation in a dose-dependent manner (Fig. 3A and B). 187 
The suppressive effects of hHB on IFN-β promoter activation were also 188 
evident in the cells stimulated with the long poly(I:C), which is a specific 189 
ligand of MDA5 (Fig. 3C). Overexpression of hHB also inhibited the 190 
transcriptions of IFN-β, GBP1, and ISG56 induced by MDA5- or long poly(I:C) 191 
(Fig. 3D–F).  192 
To further verify the contribution of hHB in MDA5-mediated signaling, we 193 
examined the impact of hHB-knockout on the IFN-β transcription. We 194 
observed that the activations of IFN-β promoter and ISRE and the 195 
transcription of IFN-β, GBP1, and ISG56 in response to long poly(I:C) or 196 
MDA5 stimulation were significantly higher in the hHB-/- cells compared with 197 
that in the wild-type HEK293T (WT) cells (Fig. 3G–K). Based on these 198 
findings, it is plausible that hHB can distinctly regulate IFN-β production 199 
through the MDA5- and RIG-I-mediated signaling pathways.  200 
 201 
hHB regulates the replication of RNA viruses through the RIG-I- and 202 
MDA5-mediated signaling pathways. 203 
We further verified the contribution of hHB-mediated regulation of the 204 
RIG-I- and MDA5-mediated signaling to the replication of RNA viruses. We 205 
generated MDA5-deficient HEK293T (MDA5-/-) and RIG-I-deficient HEK293T 206 
(RIG-I-/-) cells and overexpressed hHB in the MDA5-/- and RIG-I-/- cells (Fig. 207 
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4A) to investigate the relevance of hHB and the replication of RNA viruses in 208 
these cells. The results showed that overexpression of hHB led to the 209 
resistance against SeV, VSV, or NDV in the MDA5-/- cells but enhanced the 210 
replication of these viruses in the RIG-I-/- cells (Fig. 4B and C). Moreover, 211 
although hHB also promoted the replication of EMCV in the RIG-I-/- cells, it 212 
displayed little impact on the replication of EMCV in the MDA5-/- cells (Fig. 4B 213 
and C).  214 
In order to further assess the combinatorial impacts of RLR and hHB on 215 
viruses, we next generated double knockout cells deficient in MDA5 and hHB 216 
(MDA5-/-/hHB-/-) or RIG-I and hHB (RIG-I-/-/hHB-/-) (Fig. 4D). MDA5-/-/hHB-/- 217 
cells showed higher viral replication when infected with SeV, VSV, or NDV 218 
compared with MDA5-/- cells, but exhibited similar replication level of EMCV 219 
with MDA5-/- cells (Fig. 4E). Moreover, deficiency of hHB in RIG-I-/- cells led to 220 
the resistance to SeV, VSV, NDV, or EMCV infection (Fig. 4F). Taken together, 221 
these results indicate that hHB can differently regulate the defense response 222 
of host cells to RNA viruses through the RIG-I- and MDA5-mediated antiviral 223 
signaling pathway. 224 
 225 
hHB has no effect on the expression of RIG-I or MDA5. 226 
After establishing the relationship between hHB and the MDA5/RIG-I 227 
pathways in regulating IFN-β, we explored whether hHB affects the 228 
expression of RIG-I or MDA5. HEK293T cells cotransfected with hHB and 229 
either RIG-I or MDA5 were used to monitor the expression of RIG-I or MDA5. 230 
The results showed that overexpression of hHB failed to alter the exogenous 231 
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protein expression of RIG-I and MDA5 at all the tested gradient doses (Fig. 232 
5A and B). In addition, the mRNA levels of RIG-I and MDA5 remained 233 
unchanged upon overexpression of hHB (Fig. 5C and D). There was also no 234 
difference between the mRNA levels of RIG-I or MDA5 in the hHB-/- cells and 235 
the WT cells (Fig. 5E). Finally, we demonstrated that the endogenous 236 
expression of RIG-I and MDA5 remained unaffected in hHB-overexpressing 237 
cells (Fig. 5F). Correspondingly, there are no differences observed in the 238 
endogenous expression of RIG-I or MDA5 in the hHB-/- cells and the WT cells 239 
(Fig. 5G). 240 
 241 
hHB interferes with the MDA5-dsRNA interaction and enhances the 242 
ubiquitination of RIG-I. 243 
The results presented so far clearly articulate the involvement of 244 
RIG-I/MDA5 in mediating the hHB-dependent regulation of type I IFN 245 
pathway without affecting the RIG-I/MDA5 protein expression. We next 246 
mechanistically investigated whether hHB affects the functions of these RLRs. 247 
Previous studies have demonstrated that sensing different types of viral RNA 248 
is required for the activation of MDA5 and RIG-I to initiate their signal 249 
transductions (35-37). RIG-I and MDA5 also recognize short poly(I:C) and 250 
long poly(I:C) as the synthetic dsRNA analogues respectively (38). Thus, we 251 
examined whether hHB affected the interaction between RIG-I or MDA5 and 252 
dsRNA using short or long poly(I:C)-binding assay. The results showed that 253 
RIG-I interacted with short poly(I:C) independent of hHB (Fig. 6A). However, 254 
overexpression of hHB significantly inhibited the interaction of MDA5 with 255 
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long poly(I:C) (Fig. 6B), and long poly(I:C) interacted with MDA5 more 256 
effectively in the hHB-/- cells than in the WT cells (Fig. 6C), indicating that hHB 257 
acts as a repressor of MDA5 activation by inhibiting the MDA5-dsRNA 258 
interaction. Since RLRs interact with dsRNA and hHB interferes with this 259 
activity of MDA5, we next determined the interaction between hHB and 260 
dsRNA. Interestingly, hHB was precipitated with long poly(I:C) but not with 261 
short poly(I:C) (Fig. 6D). Due to the association of hHB with dsRNA and the 262 
involvement of hHB in MDA5-dsRNA interaction, we were interested to 263 
investigate if the interaction with the dsRNA occurs at the interface of hHB 264 
and MDA5. Co-immunoprecipitation analysis indicated no identifiable 265 
interaction of hHB with either MDA5 or RIG-I (Fig. 6E). These results imply 266 
the possibility that the hHB binding to dsRNA may compete for the interaction 267 
of MDA5 with the dsRNA ligand and this competition may result in the 268 
reduction of IFN-β induction.  269 
Upon interacting with the dsRNA ligand, the ubiquitination of RIG-I or 270 
MDA5 occurs before recruitment to the mitochondria-associated membrane 271 
and binding to MAVS (39). It suggested that the ubiquitination of RIG-I and 272 
MDA5 is crucial for the activation of RLRs signaling. Thus, we evaluated the 273 
ubiquitination of RIG-I and MDA5 upon hHB overexpression. Based on the 274 
disruption of MDA5-dsRNA interaction by hHB, the ubiquitination of MDA5 275 
was certainly suppressed by hHB in a dose-dependent manner (Fig. 6F). 276 
However, the ubiquitination of RIG-I was potentiated by increasing hHB 277 
protein expression (Fig. 6G). It has been shown that RIG-I has different 278 
ubiquitination forms and the K63-linked ubiquitination of RIG-I is positively 279 
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required for RIG-I activation, whereas the K48-linked ubiquitination will result 280 
in the destabilization of RIG-I (22, 40). To verify if hHB promotes RIG-I 281 
activation through potentiating RIG-I ubiquitination, we constructed two 282 
ubiquitin mutants in which all lysine residues were replaced with arginine 283 
except K48 or K63 (HA-K48Ub or HA-K63Ub). The results showed that hHB 284 
enhanced the K63-linked but not the K48-linked RIG-I ubiquitination (Fig. 6H). 285 
Moreover, the total ubiquitination of RIG-I and K63-linked RIG-I ubiquitination 286 
were lower in hHB-/- cells than that in WT cells (Fig. 6I). In addition, to uncover 287 
whether the action of hHB is characteristic or non-characteristic, we also 288 
examined whether the alpha subunit of hemoglobin (hHA) has similar effects 289 
on the activation of RIG-I or MDA5. The results showed that both the 290 
RIG-I-short poly(I:C) and the MDA5-long poly(I:C) interactions were 291 
independent of hHA (Fig. 6J). Furthermore, the ubiquitination of MDA5 292 
remained unchanged by hHA (Fig. 6K), but the ubiquitination of RIG-I was 293 
enhanced by hHA in a dose-dependent manner (Fig. 6L). Moreover, hHA 294 
could promote the short poly(I:C)-induced transcription of IFN-β but not the 295 
long poly(I:C)-induced transcription of IFN-β (Fig. 6M). These data imply that 296 
the inhibition of the MDA5-dsRNA interaction is a characteristic of hHB. 297 
 298 
Reactive oxygen species (ROS) is required for the hHB-induced 299 
upregulation of the RIG-I signaling pathway.  300 
Considering that hemoglobin is able to regulate the production of ROS, 301 
which is a key factor for the host cell to trigger an efficient activation of 302 
immunity (41-43), we evaluated if ROS was involved in the hHB-mediated 303 
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regulation of RIG-I or MDA5 signaling pathway. So, we first explored the links 304 
among hHB, ROS, and virus infections. hHB was overexpressed in HEK293T 305 
cells and ROS production was monitored by using the oxidant-sensitive 306 
fluorescent detection probe DCFH-DA. The results demonstrated that the 307 
hHB increased intracellular ROS accumulation in a dose dependent manner 308 
(Fig. 7A). In addition, the intracellular ROS accumulation was also 309 
upregulated by SeV in a dose-dependent manner (Fig. 7B). Thus, we also 310 
monitored the effect of hHB on the ROS accumulation in SeV-infected cells. 311 
The overexpression of hHB promoted the ROS production in a dose 312 
dependent manner at the early time of SeV infection (Fig. 7C). However, the 313 
hHB-overexpressed cells showed lower intracellular ROS accumulation at the 314 
later time of SeV infection as the replication of SeV was suppressed (Fig. 7D). 315 
Consistently, SeV induced lower ROS production in hHB-/- cells at the earlier 316 
time compared with the WT cells, but the hHB-/- cells accumulated more 317 
intracellular ROS at the later time of SeV infection (Fig. 7E). 318 
Next, we investigated if ROS is required for the hHB-mediated regulation 319 
of the MDA5 signaling pathway. As shown in Fig. 8A and B, MDA5- or 320 
RIG-induced IFN-β transcription was significantly reduced by tempol (a ROS 321 
inhibitor). Moreover, hHB still suppressed long poly(I:C)-induced activation of 322 
IFN-β promoter in the presence of tempol (Fig. 8C). Accordingly, tempol 323 
treatment could not counteract the inhibition of the MDA5- or long 324 
poly(I:C)-induced transcription of IFN-β by hHB overexpression (Fig. 8D). To 325 
exclude the unspecific effects of tempol and the disturbance of the 326 
RIG-I-mediated signaling pathway, two other ROS inhibitors, 327 
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diphenyleneiodonium chloride (DPI) and N-acetyl-L-cysteine (NAC) were also 328 
tested in the RIG-I-/- cells. DPI or NAC treatment also had no effect on the 329 
hHB-mediated inhibition of the MDA5- or long poly(I:C)-induced transcription 330 
of IFN-β in the RIG-I-/- cells (Fig. 8E). However, hHB-induced upregulation of 331 
the IFN-β promoter activation in response to short poly(I:C) was inhibited by 332 
tempol (Fig. 8F). Tempol also suppressed the hHB-induced upregulation of 333 
the RIG-I- or short poly(I:C)-induced transcription of IFN-β (Fig. 8G). 334 
Moreover, DPI or NAC also obviously counteracted the hHB-mediated 335 
facilitation of RIG-I- or short poly(I:C)-induced IFN-β transcription in the 336 
MDA5-/- cells (Fig. 8H). Thus, we evaluated the effects of hHB on the 337 
ubiquitination of RIG-I upon tempol treatment. Consistent with previous 338 
findings, when ROS was suppressed, the ubiquitination of RIG-I was no 339 
longer enhanced by hHB (Fig. 8I). To further verify the role of ROS in the 340 
hHB-mediated regulation of RIG-I activation, we investigated the effects of 341 
hHB on the K63-linked RIG-I ubiquitination when the ROS was suppressed. 342 
The results showed that the K63-linked ubiquitination of RIG-I was no longer 343 
enhanced by hHB when the ROS accumulation was inhibited (Fig. 8J). These 344 
implicate that the upregulation of the RIG-I signaling by hHB is probably 345 
related to the hHB-induced ROS, whereas hHB regulates the MDA5 signaling 346 
in an alternative way.  347 
 348 
Discussion  349 
Generally, RIG-I and MDA5, the cytoplasmic RNA helicase proteins, are 350 
the main sensors of RNA viruses in triggering type I IFNs in eukaryotes (3, 4). 351 
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Exploring the molecular events of the RIG-I/MDA5 signaling pathway is 352 
critical for understanding the complex innate immune responses against RNA 353 
viruses. In this study, we identified hHB as a novel innate immune regulator of 354 
the RIG-I/MDA5-mediated antiviral signaling pathways, which further 355 
advances our understanding of the regulatory mechanisms involved in the 356 
RLRs-mediated signaling pathways. 357 
The activation of RIG-I or MDA5 is a complex regulatory process, 358 
including viral RNA binding, structural rearrangement, dephosphorylation, 359 
ubiquitination, and binding to MAVS to activate the downstream antiviral 360 
signaling (44-46). Despite functional overlaps between the RIG-I and MDA5 361 
pathways, our results showed that hHB could differently regulate these 362 
signaling pathways. RIG-I and MDA5 recognize differential viral RNAs (12). In 363 
our study, hHB significantly inhibited the replication of SeV, VSV, and NDV, 364 
which are mainly sensed by RIG-I, but enhanced the growth of EMCV which 365 
almost only activate MDA5-mediated signaling (Figs. 1 and 4). Moreover, we 366 
showed that hHB promoted RIG-I signaling and remarkably inhibited 367 
MDA5-mediated type I IFN production (Figs. 2 and 3). Therefore, it is 368 
plausible that hHB differently regulates RIG-I and MDA5 activation in the 369 
upstream of the MAVS-mediated signaling. RIG-I and MDA5 share a similar 370 
structural framework implicated in the viral dsRNA recognition and detection 371 
of short and long poly(I:C) as the synthetic dsRNA analogues, respectively 372 
(38, 47). Although the RIG-I recognition of viral RNA has been mostly clarified, 373 
how MDA5 recognizes viral RNA is yet to be determined. Our results 374 
demonstrated that hHB had no obvious influence on the binding of short 375 
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poly(I:C) to RIG-I, but hHB acted as a direct repressor of MDA5 by interfering 376 
with the interaction between MDA5 and long poly(I:C) (Fig. 6B and C). In 377 
addition, hHB could bind to the long poly(I:C) but it failed to interact with short 378 
poly(I:C) or MDA5 and RIG-I (Fig. 6D–F). These data imply that hHB-dsRNA 379 
may compete with the MDA5-dsRNA interaction and thus negatively 380 
regulates the MDA5-mediated IFN pathway. Moreover, ubiquitination plays a 381 
critical role in the regulation of RIG-I and MDA5 activation (3). The E3 382 
ubiquitin ligases TRIM25-catalyzed K63-linked ubiquitination of RIG-I and the 383 
TRIM65-catalyzed K63-linked ubiquitination of MDA5 positively regulate 384 
RIG-I- and MDA5-mediated signaling pathways, respectively (40, 48). In the 385 
present study, we found that hHB promoted the K63-linked ubiquitination of 386 
RIG-I, whereas it inhibited the MDA5 ubiquitination (Fig. 6G–I). Interestingly, 387 
our results showed that hHA had a similar effect on the activation of RIG-I that 388 
it promotes the RIG-I ubiquitination after RNA virus infection. These findings 389 
suggest that the action of hHB on the MDA5-dsRNA interaction is 390 
characteristic, but the ability of hHB to facilitate the activation of RIG-I may 391 
owe to the general characteristic of hemoglobin. 392 
Hemoglobin is the main respiratory protein in vertebrates and many 393 
invertebrates. It exerts multiple functions and plays an important role in 394 
resistance to pathogens invasion (31). Besides functioning as a major host 395 
respiratory protein, hemoglobin also can be specifically activated by 396 
pathogens to produce ROS to constitute a part of the host defense strategy 397 
(41, 49, 50). For example, human hemoglobin significantly enhances the 398 
ROS production under microbial proteases stimulation but not the host 399 
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proteases stimulation (51). ROS plays a key role in immunity and 400 
pathogen-killing (52-54). The host respiratory proteins directly exploit the 401 
invasion of microbes to produce ROS, resulting in localized cytotoxicity to 402 
rapidly kill the neighboring pathogens (51, 55). Recently, the association of 403 
ROS with the RLRs signaling has been reported. The host cell requires ROS 404 
to efficiently trigger the RIG-I-mediated IRF3 activation and IFN-β expression 405 
(56). This implicates that ROS may provide a mediator for hHB to be involved 406 
the regulation of the RIG-I signaling. Here, we demonstrated that hHB 407 
increases the ROS level in cells and the antioxidant inhibitors including 408 
tempol, DPI, and NAC could counteract the hHB-mediated upregulation of the 409 
RIG-I-mediated signaling pathway, but could not eliminate the effects of hHB 410 
on MDA5 signaling (Figs. 8). Moreover, inhibition of ROS by tempol 411 
suppresses the hHB-mediated facilitation of RIG-I ubiquitination, especially 412 
the K63-linked ubiquitination of RIG-I. These certify that ROS is required for 413 
the hHB-mediated regulation of RIG-I ubiquitination, which indirectly 414 
promotes the activation of the RIG-I signaling.  415 
The innate immune system has evolved various strategies to prevent 416 
harmful overproduction of type I IFNs during viral infection. Thus, several host 417 
molecules are capable of regulating the type I IFN production via multiple 418 
pathways, including the RIG-I/MDA5 signaling pathway. For example, DAK is 419 
a specific repressor of the MDA5-mediated signaling and the deubiquitinating 420 
activity of A20 inhibits the RIG-I-mediated signaling (19, 23). It is also worth 421 
noticing that several host factors adopted multiple ways to regulate the 422 
RIG-I/MDA5 signaling. For example, IFN-β levels are increased following 423 
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stimulation with activators of the RIG-I signaling in protein kinase R 424 
(PKR)-null cells and the absence of PKR severely impairs the 425 
MDA5-mediated IFN induction (57). In this study, we identified that hHB was a 426 
pleiotropic regulator of the RIG-I/MDA5-mediated signaling pathway. 427 
Moreover, hHB could affect RIG-I/MDA5 signaling in a direct or indirect 428 
manner. hHB directly inhibits the binding of MDA5 to dsRNA and negatively 429 
regulates the MDA5-mediated IFN production (Fig. 9). On the other hand, 430 
hHB is involved in the regulation of cellular oxidative stress to enhance the 431 
RIG-I ubiquitination, which indirectly promotes the RIG-I-mediated IFN 432 
production (Fig. 9). These findings imply that hHB contributes to the 433 
safeguard mechanisms needed for controlling the RLR signaling pathway.  434 
Currently, many regulators have been identified to have direct effects on 435 
a single point or a single pathway of antiviral innate immunity (58-60). For 436 
these regulators, the direct effects are appreciated and emphatically studied. 437 
However, their indirect impacts on intercellular microenvironment, such as 438 
redox state, pH, and ion leakage, are relatively ignored. In the present study, 439 
although hHB can directly inhibit type I IFN production through interfering with 440 
the MDA5-mediated signaling pathway, hHB-induced change of the 441 
intercellular redox state will concurrently impede this inhibition through 442 
promoting the RIG-I-mediated signaling pathway. This reveals the importance 443 
of intercellular microenvironment in the regulation of antiviral innate immunity 444 
and implies the reason why the effects of some regulators are always 445 
fluctuating in response to the nature of stimuli. Owing to these indirect effects 446 
of hHB through influencing cellular microenvironment, the hHB-mediated 447 
20 
 
innate immune regulation may be dependent on the cellular state and 448 
stimulus types and so on, rather than only dependent on its expression level. 449 
Therefore, future work is required to further understand the regulation 450 
mechanisms of antiviral innate immunity and to improve the effectiveness of 451 
some regulators. 452 
In summary, we identified hHB as a novel innate immune regulator of 453 
RNA viruses through multifunctional and pleiotropic regulation of the 454 
RIG-I/MDA5 signaling pathways. On one hand, hHB promoted the 455 
RIG-I-mediated signaling pathway by enhancing the RIG-I ubiquitination. On 456 
the other hand, hHB remarkably inhibited MDA5-mediated type I IFN 457 
production through interfering with the MDA5-dsRNA interaction. We 458 
mechanistically illustrated the crucial roles of hHB in regulation and safeguard 459 
needed for antiviral innate immunity. Our findings also highlight the 460 
importance of the intercellular microenvironment such as redox state in the 461 
regulation of antiviral innate immunity and thus warrant future studies to fully 462 
explore the complex induction of innate immunity. 463 
 464 
Materials and methods 465 
Cells, viruses, and plasmids. 466 
HEK293T (ATCC® CRL-3216™) cells, a human embryonic kidney cell 467 
line, and BHK-21 (ATCC® CCL-10), a baby hamster Syrian kidney cell line, 468 
obtained from the American Type Culture Collection (ATCC), were cultured in 469 
Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum 470 
(FBS). SeV and NDV-GFP were propagated in SPF chicken embryos and 471 
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titrated in chicken red blood cells by hemagglutination assay. EMCV and 472 
VSV-GFP were propagated in BHK-21 cells. The p3Flag-hHB plasmid 473 
encoding the hHB protein (GenBank accession no. NM_000518.4) with the 474 
3×Flag tag at its N-terminus was constructed by cloning the hHB cDNA into 475 
the p3Flag-CMV-10 vector (Sigma-Aldrich). The plasmids pEGFP-RIG-I and 476 
pEGFP-MDA5 encoding the RIG-I and MDA5 proteins, respectively, with a 477 
GFP tag at the C-terminus were constructed by cloning the human RIG-I, 478 
MDA5, and MAVS cDNA into the pEGFP-C1 vector (Clontech Laboratories). 479 
pEF-Myc-RIG-I and pEF-Myc-MDA5 encode the human RIG-I and MDA5, 480 
respectively.  481 
 482 
Generation of hHB-/-, -RIG-I-/-, and -MDA5-/- cells using HEK293T cells.  483 
We generate hHB-/-, -RIG-I-/-, and -MDA5-/- cells using the lentiviral 484 
expressing CRISPR-Cas9 vector (lentiCRISPRv2, Addgene). The hHB-, 485 
RIG-I-, and MDA5-specific sgRNA sequences were: hHB (forward, 5′- GTA 486 
ACG GCA GAC TTC TCC TC-3′; reverse, 5′-GAG GAG AAG TCT GCC GTT 487 
ACC-3′), RIG-I (forward, 5′-GGG TCT TCC GGA TAT AAT CC-3′; reverse, 488 
5′-GGA TTA TAT CCG GAA GAC CCC-3′), and MDA5 (forward, 5′-CGA ATT 489 
CCC GAG TCC AAC CA-3′; reverse, 5′-TGG TTG GAC TCG GGA ATT 490 
CGC-3′), respectively. Lenti-CRISPR virions were packaged in HEK293T 491 
cells by transfecting the psPAX2 plasmid (Addgene), the pMD2.G plasmid 492 
(Addgene) and either the lentiCRISPRv2 vector containing hHB, RIG-I, or 493 
MDA5-specific sgRNA, or empty lentiCRISPRv2 plasmid as a control. 494 
The suspensions were harvested at 72 hours posttransfection (hpt). 495 
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HEK293T cells were infected with the suspensions and treated with 1.5 μg/ml 496 
puromycin for 5 d. The cells were lysed and the hHB, RIG-I, or MDA5 497 
expression was analyzed by Western blotting. 498 
 499 
Dual-luciferase reporter assay. 500 
HEK293T cells were cotransfected with the IFN-β promoter or ISRE 501 
firefly luciferase (FLuc) reporter plasmid (pIFN-β-FLuc or pISRE-FLuc), the 502 
indicated amounts of p3Flag-hHB, and internal reference reporter 503 
TK-Renilla luciferase (RLuc) as an internal control (pRLuc-TK). The total 504 
amounts of the plasmid DNAs were equalized with the empty control vector 505 
p3Flag-CMV-10 (p3Flag-EV). At 24 hpt, the cells were infected with SeV or 506 
PBS for another 24 h. Then cells were lysed and the activities of the reporter 507 
genes were determined using a Dual-Luciferase® Reporter Assay System 508 
10-Pack (Promega). The luciferase induction mediated by IFN-β promoter 509 
(IFN-β-Luc) or ISRE (ISRE-Luc) was presented as relative expression level of 510 
FLuc/RLuc. For the RIG-I- or MDA5-mediated response, HEK293T cells were 511 
cotransfected with pIFN-β-FLuc/pISRE-FLuc and pRLuc-TK as well as 512 
pMyc-RIG-I, pMyc-MDA5, short poly(I:C) (catalog no. tlrl-picw; InvivoGen), or 513 
long poly(I:C) (catalog no. tlrl-pic; InvivoGen). The luciferase activities were 514 
measured at 24 hpt and relative expressions were calculated as described 515 
above. 516 
 517 
Real-time RT-PCR. 518 
Total RNA was extracted from HEK293T cells using the TRIzol reagent 519 
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(catalog no. 15596026; Invitrogen). RNAs were converted to cDNA using 520 
Reverse Transcriptase XL (catalog no. 2621; TaKaRa). The transcription 521 
levels of IFN-β, RIG-I, and MDA5 in hHB-treated or untreated HEK293T cells 522 
with or without SeV infection were quantified by the 2−ΔΔCT Method (61). The 523 
mRNA level of GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was 524 
set as an internal loading control. Primers used for the real-time RT-PCR are 525 
listed in Table 1. 526 
 527 
ROS production assay. 528 
Total ROS production was measured by probing with the 529 
2’,7’-dichlorodihydrofluorescein diacetate (DCHF-DA) probe (catalog no. 530 
S0033; Beyotime Biotechnology) and was evaluated using Enspire 531 
Multimode Plate Reader (Perkin Elmer). The HEK293T cells were transfected 532 
with p3Flag-hHB at the indicated amounts. The total amount of the plasmid 533 
DNA was equalized with the p3Flag-EV. At 24 hpt, the cells were infected 534 
with SeV or treated with PBS for 24 h. Then the cells were washed with PBS 535 
and incubated with the DCFH-DA probes for 30 min at 37°C. After incubation, 536 
the cells were washed twice with PBS and the 2’,7’-dichlorofluorescein (DCF) 537 
fluorescence was measured. 538 
 539 
Western blotting. 540 
Equivalent amount of each sample was resolved by SDS-PAGE and 541 
transferred to nitrocellulose membranes (Hybond-C Super; GE Healthcare). 542 
The membranes were blocked with 5% skim milk in PBS containing 0.1% 543 
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Tween (PBST) and incubated for 2 h at room temperature with the primary 544 
antibodies at an appropriate dilution (anti-Flag, -Myc, -MDA5, and -RIG-I 545 
MAbs at 1:1,000 and anti-hHB MAb at 1:500) (catalog nos. F1804 and M4439; 546 
Sigma-Aldrich and catalog nos. sc-134513, sc-48932, and sc-22718; Santa 547 
Cruz). The membranes were washed by PBST and then incubated with 548 
IRDye® 800CW goat anti-mouse IgG (H+L), donkey anti-goat IgG (H+L), and 549 
goat anti-rabbit (H+L) (catalog nos. 926-32210, 926-32214, and 926-32211; 550 
LiCor BioSciences) or goat anti-mouse IgG-peroxidase (catalog no. A5278; 551 
Sigma) at 1:10,000 for 1 h at 37°C, and the blots were scanned using the 552 
Odyssey infrared imaging system (LiCor BioSciences) or 553 
Fluorescence/Chemiluminescence imaging system (Clinx Science 554 
instruments). 555 
 556 
Coimmunoprecipitation (Co-IP) assay. 557 
HEK293T cells were transfected with p3Flag-hHB together with 558 
pMyc-RIG-I or pMyc-MDA5. At 48 hpt, the cells were lysed with NP-40 buffer 559 
(catalog no. P0013F; Beyotime) with 1 mM phenylmethylsulfonyl ﬂuoride 560 
(PMSF) at 4°C for 30 min. The supernatants were collected and precleared 561 
with protein G-agarose (catalog no. 11243233001; Roche) for 2 h at 4°C. 562 
Then the mixtures were centrifuged and the supernatants were incubated 563 
with an anti-Flag M2 affinity gel (catalog no. A2220; Sigma-Aldrich) overnight 564 
at 4°C. The gels were washed with the NP-40 buffer and the precipitated 565 




Poly(I:C) binding assay. 568 
HEK293T cells were transiently transfected with pMyc-MDA5 or 569 
pMyc-RIG-I and p3Flag-hHB plasmids and lysed with NP-40 buffer 570 
containing Recombinant RNase Inhibitor (RRI) (catalog no. 2313A; TaKaRa). 571 
Poly(I:C) was labeled with photobiotin (catalog no. A14216; Baomanbio) 572 
using a mercury vapor lamp. The cell lysates were incubated with the labeled 573 
poly(I:C) for 4 h at 4°C. Then the biotinylated RNA-protein compounds were 574 
precipitated with Dynabeads® Streptavidin (catalog no. 11205D; Invitrogen) 575 
for 1 h at room temperature using gentle rotation. After washing with PBS, the 576 
bound proteins were analyzed by Western blotting analysis. 577 
 578 
Statistical analysis. 579 
All experiments were performed with at least three independent 580 
replicates. Results were analyzed by SPSS 18.0 software using Student’s t 581 
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 772 
Figure legends 773 
Fig. 1. hHB is involved in the antiviral responses to RNA viruses. (A) The 774 
expression of hHB in different non-erythroid cell lines including HEK293T, 775 
HepG2, A549, HeLa, and THP-1. (B) The knockout efficiency of hHB in 776 
hHB-deficient HEK293T (hHB-/-) cells compared with the expression level of 777 
hHB in the wild-type HEK293T (WT) and the overexpression of hHB in 778 
HEK293T cells. (C) hHB-/- cells were more sensitive to Sendai virus (SeV), 779 
vesicular stomatitis virus (VSV), and Newcastle disease virus (NDV) but more 780 
resistant to encephalomyocarditis virus (EMCV). hHB-/- and WT cells were 781 
infected with SeV or EMCV for 24 h and the RNA level of the SeV N protein or 782 
the EMCV 3D protein was determined by real-time RT-PCR. In addition, 783 
hHB-/- and WT cells were infected with VSV-GFP or NDV-GFP for 48 h. The 784 
GFP expression level was analysed by Western blotting. (D) Overexpression 785 
of hHB inhibited the replications of SeV, VSV, and NDV but enhanced EMCV 786 
growth. HEK293T cells were transfected with p3Flag empty vector 787 
(p3Flag-EV) or p3Flag-hHB for 24 h and then infected with SeV or EMCV 788 
for 24 h or infected with VSV-GFP or NDV-GFP for 48 h. The RNA level of the 789 
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SeV N protein or the EMCV 3D protein or the GFP expression of VSV-GFP or 790 
NDV-GFP was tested. The data represent the mean ± standard deviation 791 
from three independent experiments. Significant differences are denoted by * 792 
(P < 0.05), ** (P < 0.01), or *** (P < 0.001). 793 
 794 
Fig. 2. hHB enhances the RIG-I-mediated antiviral signaling. (A–C) 795 
Overexpression of hHB upregulated RIG-I-mediated activation of the IFN-β 796 
promoter and ISRE. HEK293T cells were cotransfected with the indicated 797 
amounts of p3Flag-hHB (hHB), pMyc-RIG-I, TK-Renilla luciferase (RLuc) 798 
internal reference reporter plasmid (pRLuc-TK), and firefly luciferase (FLuc) 799 
reporter plasmid (pIFN-β-FLuc) (A) or ISRE firefly luciferase reporter plasmid 800 
(pISRE-FLuc) (B) for 24 h. Additionally, HEK293T cells were cotransfected 801 
with pRLuc-TK, pIFN-β-FLuc, short poly(I:C), and the indicated amounts of 802 
p3Flag-hHB for 24 h (C). The activation of the IFN-β promoter or ISRE was 803 
presented as the activities of the luciferase reporter genes induction mediated 804 
by the IFN-β promoter (IFN-β-Luc induction) or ISRE (ISRE-Luc induction) 805 
and calculated as the relative levels of FLuc/RLuc. (D–F) Overexpression of 806 
hHB enhanced the transcription of IFN-β, GBP1, and ISG56. HEK293T cells 807 
were cotransfected with p3Flag-EV (EV) or p3Flag-hHB and pMyc-RIG-I or 808 
short poly(I:C) for 24 h and the IFN-β (D), GBP1 (E), and ISG56 (F) mRNA 809 
levels in cells were analyzed using real-time RT-PCR. (G and H) The RIG-I 810 
mediated lower activation of the IFN-β promoter and ISRE in hHB-/- cells. 811 
hHB-/- and WT cells were cotransfected with pMyc-RIG-I or short poly(I:C) as 812 
well as pRLuc-TK and pIFN-β-FLuc (G) or pISRE-FLuc (H). At 24 hpt, the 813 
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activation of IFN-β promoter or ISRE was tested. (I–K) The RIG-I mediated 814 
lower transcription of IFN-β, GBP1, and ISG56 in hHB-/- cells. hHB-/-, and WT 815 
cells were transfected with pMyc-RIG-I or short poly(I:C). At 24 hpt, the IFN-β 816 
(I), GBP1 (J), and ISG56 (K) mRNA abundances were tested. (L) The effect 817 
of hHB on the IFN-β promoter activation. HEK293T cells were cotransfected 818 
with the indicated amounts of p3Flag-hHB, pRLuc-TK, and pIFN-β-FLuc for 819 
24 h. The IFN-β promoter activation was tested as described above. The data 820 
represent the mean ± standard deviation from three independent experiments. 821 
Significant differences are denoted by * (P < 0.05), ** (P < 0.01), or *** (P < 822 
0.001). NS, not significant (P > 0.05). 823 
 824 
Fig. 3. hHB inhibits the MDA5-mediated antiviral signaling. (A–C) 825 
Overexpression of hHB suppressed MDA5-mediated activation of the IFN-β 826 
promoter and ISRE. HEK293T cells were cotransfected with the indicated 827 
amounts of p3Flag-hHB, pMyc-MDA5, pRLuc-TK, and pIFN-β-FLuc (A) or 828 
pISRE-FLuc (B) for 24 h. Additionally, HEK293T cells were cotransfected with 829 
pRLuc-TK, pIFN-β-FLuc, long poly(I:C), and the indicated amounts of 830 
p3Flag-hHB for 24 h (C). The effect of hHB on the activation of IFN-β 831 
promoter or ISRE was examined as described above. (D–F) Overexpression 832 
of hHB decreased the transcription of IFN-β, GBP1, and ISG56. HEK293T 833 
cells were transfected with the p3Flag-EV (EV) or p3Flag-hHB and 834 
pMyc-MDA5 or long poly(I:C) for 24 h and the IFN-β (D), GBP1 (E), and 835 
ISG56 (F) mRNA levels in cells were analyzed. (G and H) The MDA5 836 
mediated higher activation of the IFN-β promoter and ISRE in hHB-/- cells. 837 
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hHB-/- and WT cells were cotransfected with pMyc-MDA5 or long poly(I:C) as 838 
well as pRLuc-TK and pIFN-β-FLuc (G) or pISRE-FLuc (H). At 24 hpt, the 839 
activation of IFN-β promoter or ISRE was analyzed. (I–K) The MDA5 840 
mediated higher transcription of IFN-β, GBP1, and ISG56 in hHB-/- cells. 841 
hHB-/- and WT cells were transfected with pMyc-MDA5 or long poly(I:C). At 24 842 
hpt, the IFN-β (I), GBP1 (J), and ISG56 (K) mRNA abundances were tested. 843 
The data represent the mean ± standard deviation from three independent 844 
experiments. Significant differences are denoted by * (P < 0.05), ** (P < 0.01), 845 
or *** (P < 0.001). NS, not significant (P > 0.05). 846 
 847 
Fig. 4. hHB regulates the RIG-I- and MDA5-mediated antiviral response 848 
to RNA viruses. (A) The knockout efficiency of RIG-I and MDA5 in HEK293T 849 
cells, and overexpression of hHB in MDA5-deficient HEK293T (MDA5-/-) and 850 
RIG-I-deficient HEK293T (RIG-I-/-). (B and C) The effect of 851 
hHB-overexpression on the replications of SeV, VSV, NDV, and EMCV in 852 
MDA5-/- and RIG-I-/- cells. MDA5-/- (B) or RIG-I-/- (C) cells were transfected 853 
with p3Flag-hHB for 24 h and then were infected with SeV or EMCV for 24 h 854 
or infected with VSV-GFP or NDV-GFP for 48 h. The RNA level of the SeV N 855 
protein or the EMCV 3D protein or the GFP expression level of VSV-GFP or 856 
NDV-GFP was tested. (D) The knockout efficiency of RIG-I and MDA5 in 857 
hHB-/- cells. (E and F) Deficiency of hHB differently affected the replication of 858 
SeV, VSV, NDV, and EMCV in RIG-I-/- and MDA5-/- cells. MDA5-/-/hHB-/- cells 859 
and MDA5-/- (E) or RIG-I-/-/hHB-/- and RIG-I-/- cells (F) were infected with SeV 860 
or EMCV for 24 h or infected with VSV-GFP or NDV-GFP for 48 h. Then the 861 
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RNA level of the SeV N protein or the EMCV 3D protein or the GFP 862 
expression level of VSV-GFP or NDV-GFP was measured as above. The data 863 
represent the mean ± standard deviation from three independent experiments. 864 
Significant differences are denoted by * (P < 0.05), ** (P < 0.01), or *** (P < 865 
0.001). NS, not significant (P > 0.05). 866 
 867 
Fig. 5. hHB does not affect RIG-I or MDA5 expression. (A and B) 868 
Overexpression of hHB had no effects on the exogenous protein expression 869 
of RIG-I or MDA5. HEK293T cells were cotransfected with the indicated 870 
amounts of p3Flag-hHB and pMyc-RIG-I or pMyc-MDA5 for 24 h and the 871 
RIG-I (A) and MDA5 (B) expression was analyzed by Western blotting. (C and 872 
D) Overexpression of hHB did not affect the RIG-I and MDA5 transcription. 873 
HEK293T cells were transfected with the indicated amounts of p3Flag-hHB 874 
(hHB) for 24 h and then RIG-I (C) and MDA5 (D) mRNA levels in cells were 875 
analyzed using real-time RT-PCR. (E) The mRNA levels of RIG-I and MDA5 876 
exhibited no difference between the hHB-/- and WT cells. The mRNA levels of 877 
RIG-I and MDA5 in the cells were analyzed using real-time RT-PCR. (F) The 878 
endogenous protein expression of RIG-I and MDA5 had no change in the 879 
hHB-overexpression cells. HEK293T cells were transfected with the indicated 880 
amounts of p3Flag-hHB for 48 h and the RIG-I and MDA5 expression was 881 
analyzed by Western blotting analysis. (G) The endogenous protein 882 
expression of RIG-I and MDA5 in the hHB-/- and WT cells was examined by 883 




Fig. 6. hHB inhibits the binding of dsRNA to MDA5 but not to RIG-I and 886 
enhances the ubiquitination of RIG-I. (A) hHB has no influence on the 887 
interaction of RIG-I with short poly(I:C). HEK293T cells were cotransfected 888 
with pMyc-RIG-I and p3Flag-hHB for 48 h. Then the cells were lysed and the 889 
cell lysates were incubated with the photobiotin-labeled short poly(I:C) for 4 h 890 
at 4°C. Then the biotinylated RNA-protein compounds were precipitated with 891 
Dynabeads® Streptavidin for 1 h at room temperature. The bound proteins 892 
were applied to SDS-PAGE, and then analyzed by Western blotting. (B and C) 893 
hHB inhibits the binding of MDA5 to the long poly(I:C). HEK293T cells were 894 
transfected with pMyc-MDA5 and p3Flag-hHB (B) or the hHB-/- and the WT 895 
cells were transfected with pMyc-MDA5 (C). The cell lysates were collected at 896 
48 hpt and incubated with the photobiotin-labeled long poly(I:C) for 4 h at 4°C. 897 
Then the biotinylated RNA-protein compounds were precipitated with 898 
Dynabeads® Streptavidin for 1 h at room temperature. The bound proteins 899 
were analyzed as described above. (D) hHB interacted with long poly(I:C) but 900 
not short poly(I:C). HEK293T cells were transfected with p3Flag-hHB. At 48 901 
hpt, the cell lysates were collected and incubated with the photobiotin-labeled 902 
short poly(I:C) or long poly(I:C) for 4 h at 4°C. Then the biotinylated 903 
RNA-protein compounds were precipitated with Dynabeads® Streptavidin for 904 
1 h at room temperature. The bound proteins were analyzed by Western 905 
blotting. (E) Co-IP analysis of interaction between hHB and RIG-I or MDA5 as 906 
described in Materials and Method. (F–H) The effects of hHB on the 907 
ubiquitinations of RIG-I and MDA5. HEK293T cells were cotransfected with 908 
the indicated plasmids for 12 h and then infected with SeV for 12 h. The 909 
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prepared cell extracts were analyzed by IP analysis using an anti-Myc 910 
monoclonal antibody followed by Western blotting with the indicated 911 
antibodies. (I) The ubiquitination of RIG-I in the hHB-/- cells. The hHB-/- and 912 
the WT cells were cotransfected with the indicated plasmids for 12 h and then 913 
infected with SeV for 12 h. The prepared cell extracts were analyzed as 914 
described above followed by Western blotting with the indicated antibodies. (J) 915 
hHA has no influence on the interactions of RIG-I-short poly(I:C) and 916 
MDA5-long poly(I:C). HEK293T cells were cotransfected with pMyc-RIG-I or 917 
pMyc-MDA5 and p3Flag-hHA for 48 h. Then the cells were lysed and the cell 918 
lysates were incubated with the photobiotin-labeled short poly(I:C) or long 919 
poly(I:C) for 4 h at 4°C. Then the biotinylated RNA-protein compounds were 920 
precipitated with Dynabeads® Streptavidin for 1 h at room temperature. The 921 
bound proteins were analyzed by Western blotting. (K and L) The effect of 922 
hHA on the ubiquitination of RIG-I and MDA5. HEK293T cells were 923 
cotransfected with the indicated plasmids for 12 h and then infected with SeV 924 
for 12 h. The prepared cell extracts were analyzed as described above 925 
followed by Western blotting with the indicated antibodies. (M) 926 
Overexpression of hHA promoted the RIG-I-mediated activation of the IFN-β 927 
transcription but not the MDA5-mediated activation of the IFN-β transcription. 928 
HEK293T cells were transfected with p3Flag-EV (EV) or p3Flag-hHA and 929 
short poly(I:C) or long poly(I:C) for 24 h and the IFN-β mRNA level in cells 930 
was analyzed using real-time RT-PCR. The data represent the mean ± 931 
standard deviation from three independent experiments. Significant 932 




Fig. 7. hHB and viral infections promote the intracellular ROS 935 
accumulation. (A) hHB increased intracellular ROS accumulation. HEK293T 936 
cells were transfected with p3Flag-hHB at the indicated concentrations for 937 
24 h and then the cytoplasmic ROS formations were monitored by using the 938 
oxidant-sensitive fluorescent probe DCFH-DA as described in Materials and 939 
methods. (B) SeV infection promoted intracellular ROS accumulation. 940 
HEK293T cells were infected with 10, 20, 30, 40, or 50 hemagglutinin units 941 
(HAUs)/ml SeV for 24 h. Then the cytoplasmic ROS formations were tested. 942 
(C and D) The effect of hHB on the ROS accumulation in the SeV-infected 943 
cells. HEK293T cells were transfected with p3Flag-hHB at the indicated 944 
concentrations for 24 h and then were treated with 20 HAUs/ml SeV. Then the 945 
cytoplasmic ROS formations were measured at 12 h (C) and 48 h (D) after 946 
infection. (E) The SeV-induced ROS accumulation in hHB-/- cells. WT cells 947 
and hHB-/- cells were infected with SeV and the cytoplasmic ROS formations 948 
were measured at 12 h and 48 h after infection. The data represent the mean 949 
± standard deviation from three independent experiments. Significant 950 
differences are denoted by * (P < 0.05), ** (P < 0.01), or *** (P < 0.001).  951 
 952 
Fig. 8. Tempol inhibits hHB-induced facilitation of the RIG-I signaling 953 
pathway, but has no effect on the hHB-induced inhibition of the MDA5 954 
signaling pathway. (A) The effects of tempol on long poly(I:C)- or short 955 
poly(I:C)-induced activation of the IFN-β promoter. HEK293T cells were 956 
transfected with pRLuc-TK, pIFN-β-FLuc, and long poly(I:C) or short poly(I:C) 957 
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for 12 h and then treated with 3 mM tempol or PBS for 12 h. The effects of 958 
hHB on the IFN-β promoter activation were tested as described above. (B) 959 
The effects of tempol on long poly(I:C)- or short poly(I:C)-induced IFN-β 960 
mRNA transcription. HEK293T cells were transfected with long poly(I:C) or 961 
short poly(I:C) for 12 h and then treated with 3 mM tempol or PBS for 12 h. 962 
The IFN-β mRNA level in cells was analyzed using real-time RT-PCR. (C) 963 
Tempol suppressed hHB-induced inhibition of the activation of the IFN-β 964 
promoter in response to long poly(I:C). HEK293T cells were transfected with 965 
the 3Flag-hHB (hHB) at the indicated concentrations, in addition to 966 
pRLuc-TK, pIFN-β-FLuc, and long poly(I:C) for 12 h. Then the cells were 967 
treated with 3 mM tempol or PBS for 24 h. The effects of hHB on the IFN-β 968 
promoter activation were tested. (D) The effect of tempol on the 969 
hHB-regulation of MDA5-mediated mRNA transcription of IFN-β. HEK293T 970 
cells were transfected with the p3Flag-EV (EV) or p3Flag-hHB and 971 
pMyc-MDA5 or long poly(I:C) for 12 h. Then the cells were treated with 3 mM 972 
tempol or PBS for 12 h and the IFN-β mRNA levels in cells were analyzed 973 
using real-time RT-PCR. (E) The effect of diphenyleneiodonium chloride (DPI) 974 
and N-acetyl-L-cysteine (NAC) on the hHB-regulation of MDA5-mediated 975 
mRNA transcription of IFN-β. RIG-I-/- cells were transfected with the 976 
p3Flag-EV (EV) or p3Flag-hHB and pMyc-MDA5 or long poly(I:C) for 12 h. 977 
Then the cells were treated with 3 μM DPI, 10 mM NAC or PBS for 12 h and 978 
the IFN-β mRNA level in cells was tested. (F) Tempol suppressed 979 
hHB-induced upregulation of the activation of the IFN-β promoter in response 980 
to short poly(I:C). HEK293T cells were transfected with the p3Flag-hHB 981 
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(hHB) at the indicated concentrations, as well as pRLuc-TK, pIFN-β-FLuc, 982 
and short poly(I:C) for 12 h. Then cells were treated with 3 mM tempol or PBS 983 
for 24 h. The effects of hHB on the IFN-β promoter activation were analyzed 984 
as described above. (G) The effect of tempol on the regulation of 985 
RIG-I-mediated IFN-βmRNA transcription by hHB. HEK293T cells were 986 
transfected with the p3Flag-EV (EV) or p3Flag-hHB and pMyc-RIG-I or 987 
short poly(I:C) for 12 h. Then the cells were treated with 3 mM tempol or PBS 988 
for 12 h and the IFN-β mRNA levels in cells were analyzed using real-time 989 
RT-PCR. (H) The effect of DPI and NAC on the hHB-regulation of 990 
RIG-I-mediated mRNA transcription of IFN-β. MDA5-/- cells were transfected 991 
with the p3Flag-EV (EV) or p3Flag-hHB and pMyc-RIG-I or short poly(I:C) 992 
for 12 h. Then the cells were treated with 3 μM DPI, 10 mM NAC or PBS for 993 
12 h and the IFN-β mRNA level in cells was tested. (I and J) The effect of 994 
tempol on the hHB-induced RIG-I ubiquitination and the K63-linked RIG-I 995 
ubiquitination. HEK293T cells were cotransfected with the indicated plasmids. 996 
At 12 h after transfection, the cells were infected with SeV and 3 mM tempol 997 
for 12 h. The prepared cell extracts were analyzed as described above. (K) 998 
The effect of hHA on the ROS accumulation in the SeV-infected cells. 999 
HEK293T cells were transfected with p3Flag-hHA at the indicated 1000 
concentrations for 24 h and then were infected with SeV. Then the 1001 
cytoplasmic ROS formations were measured at 12 h after infection. The data 1002 
represent the mean ± standard deviation from three independent experiments. 1003 
Significant differences are denoted by * (P < 0.05), ** (P < 0.01) or *** (P < 1004 




Fig. 9. Schematic model of the hHB-mediated regulation of RIG-I/MDA5 1007 
signaling pathways. The specific details of the model were described in the 1008 
text. Ub, ubiquitin; ○P , phosphate group; Mito, mitochondrion. 1009 
